sorry different drug make up and zero safety problems with any of sarepta's drugs.
Sarepta has showed all to everyone when it comes to clinical safety.''gsk/prosensa never did
Why?...FDA has been working with Sarepta from the early start...
Couldnt the negative news on $GSK DMD trial be construed as negative for $SRPT since they are the same class? (No position)
Ian Estepan @ianestepan
@BioRunUp No - they use different backbones - that is the whole point - $SRPT has not shown these side effects - very positive
No. I don't think this news impacts AA one way or another. It's not as if SRPT's data has changed because of this new. High efficacy and very few safety issues.